ONE-WAYDated event · through FY2021

Development of Fibrosis Diagnostic Technology Using AI-Powered Computational Pathology

Technology development and investment in related companies aimed at improving the diagnostic accuracy of fibrotic diseases, including pulmonary and hepatic fibrosis, through AI-powered computational pathology.

Companies1How many companies write about this.

Threads1One company can carry more than one thread here.

PeriodFY2019-Q1 →Last written FY2021

Directionhelps1 helps · 0 hurts · 0 flat